Halozyme Therapeutics Inc. buy Benchmark Co.
Start price
18:15
/
50%
€64.40
Target price
03.02.27
-
Performance (%)
0.78%
Price
20:23
€64.90
Summary
This prediction is currently active. The BUY prediction by Benchmark_Co_ for Halozyme Therapeutics Inc. is nearly unchanged. This prediction currently runs until 03.02.27. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Halozyme Therapeutics Inc. | 0.78% |
| iShares Core DAX® | -0.436% |
| iShares Nasdaq 100 | 0.854% |
| iShares Nikkei 225® | 2.652% |
| iShares S&P 500 | 1.190% |
Comments by Benchmark_Co_ for this prediction
In the thread Halozyme Therapeutics Inc. diskutieren
Halozyme Therapeutics (NASDAQ:HALO) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Ratings data for HALO provided by MarketBeat
Stopped prediction by Benchmark_Co_ for Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€66.40
24.09.25
24.09.25
€76.27
24.09.26
24.09.26
-3.01%
20:23
20:23
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€54.68
20.02.25
20.02.25
€71.72
20.02.26
20.02.26
18.69%
20:23
20:23
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.87
08.08.24
08.08.24
€55.00
08.08.25
08.08.25
10.25%
09.08.25
09.08.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€48.68
25.06.24
25.06.24
€56.00
25.06.25
25.06.25
-7.99%
26.06.25
26.06.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.23
16.04.24
16.04.24
€46.98
16.04.25
16.04.25
43.42%
17.04.25
17.04.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€31.35
19.01.24
19.01.24
€45.94
19.01.25
19.01.25
69.19%
20.01.25
20.01.25
Halozyme Therapeutics Inc.
Start price
Target price
Perf. (%)
€33.23
20.10.23
20.10.23
€47.17
20.10.24
20.10.24
45.44%
21.10.24
21.10.24